AU1918001A - 5-hydroxy indazole derivatives for treating glaucoma - Google Patents

5-hydroxy indazole derivatives for treating glaucoma

Info

Publication number
AU1918001A
AU1918001A AU1918001A AU1918001A AU1918001A AU 1918001 A AU1918001 A AU 1918001A AU 1918001 A AU1918001 A AU 1918001A AU 1918001 A AU1918001 A AU 1918001A AU 1918001 A AU1918001 A AU 1918001A
Authority
AU
Australia
Prior art keywords
treating glaucoma
indazole derivatives
hydroxy indazole
hydroxy
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU1918001A
Other languages
English (en)
Inventor
Jesse A May
Zixia Feng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Alcon Universal Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Universal Ltd filed Critical Alcon Universal Ltd
Publication of AU1918001A publication Critical patent/AU1918001A/xx
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU1918001A 2000-03-17 2000-11-14 5-hydroxy indazole derivatives for treating glaucoma Pending AU1918001A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19028300P 2000-03-17 2000-03-17
PCT/US2000/031143 WO2001070701A1 (en) 2000-03-17 2000-11-14 5-hydroxy indazole derivatives for treating glaucoma

Publications (1)

Publication Number Publication Date
AU1918001A true AU1918001A (en) 2001-10-03

Family

ID=22700701

Family Applications (2)

Application Number Title Priority Date Filing Date
AU1918001A Pending AU1918001A (en) 2000-03-17 2000-11-14 5-hydroxy indazole derivatives for treating glaucoma
AU2001219180A Ceased AU2001219180B2 (en) 2000-03-17 2000-11-14 5-hydroxy indazole derivatives for treating glaucoma

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2001219180A Ceased AU2001219180B2 (en) 2000-03-17 2000-11-14 5-hydroxy indazole derivatives for treating glaucoma

Country Status (12)

Country Link
EP (1) EP1268439A1 (https=)
JP (1) JP2003535821A (https=)
KR (1) KR20030095183A (https=)
CN (1) CN1450995A (https=)
AR (1) AR026708A1 (https=)
AU (2) AU1918001A (https=)
BR (1) BR0017163A (https=)
CA (1) CA2401959A1 (https=)
MX (1) MXPA02008825A (https=)
PL (1) PL365422A1 (https=)
WO (1) WO2001070701A1 (https=)
ZA (1) ZA200206853B (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6960579B1 (en) 1998-05-19 2005-11-01 Alcon Manufacturing, Ltd. Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders
EP1392292B1 (en) 2001-06-01 2006-03-01 Alcon, Inc. Pyranoindazoles and their use for the treatment of glaucoma
TW593302B (en) 2001-12-20 2004-06-21 Alcon Inc Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma
CA2505127A1 (en) * 2002-11-08 2004-05-27 James B. Doherty Ophthalmic compositions for treating ocular hypertension
US7196082B2 (en) 2002-11-08 2007-03-27 Merck & Co. Inc. Ophthalmic compositions for treating ocular hypertension
CN100384827C (zh) * 2002-11-08 2008-04-30 默克公司 用于治疗高眼压症的眼用组合物
CA2506204A1 (en) 2002-12-13 2004-07-01 Alcon, Inc. Novel benzopyran analogs and their use for the treatment of glaucoma
JP2004262812A (ja) * 2003-02-28 2004-09-24 Rohto Pharmaceut Co Ltd 眼圧低下剤
WO2005025568A1 (en) * 2003-09-04 2005-03-24 Merck & Co., Inc. Ophthalmic compositions for treating ocular hypertension
US7129257B1 (en) 2003-12-15 2006-10-31 Alcon, Inc. Pyrazolo[3,4- e]benzoxazoles for the treatment of glaucoma
WO2005058911A2 (en) 2003-12-15 2005-06-30 Alcon, Inc. Substituted [1,4]oxazino[2,3-g]indazoles for the treatment of glaucoma
US7338972B1 (en) 2003-12-15 2008-03-04 Alcon, Inc. Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma
KR20070094747A (ko) 2004-11-29 2007-09-21 워너-램버트 캄파니 엘엘씨 치료용 피라졸로［３,４-ｂ］피리딘 및 인다졸
WO2006062839A1 (en) 2004-12-08 2006-06-15 Alcon, Inc. Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma
KR100972921B1 (ko) * 2009-12-02 2010-07-28 제이케이이앤씨 주식회사 회전 격판식 선회류 세정 및 탈취장치
WO2025000053A1 (en) * 2023-06-28 2025-01-02 Psylo Pty Ltd Compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2680366B1 (fr) * 1991-08-13 1995-01-20 Adir Nouveaux derives d'arylethylamines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
JP2002515408A (ja) * 1998-05-19 2002-05-28 アルコン ラボラトリーズ， インコーポレーテッド 眼および中枢神経系疾患治療用セロトニン作動性５ｈｔ７受容体化合物
GB9819020D0 (en) * 1998-09-01 1998-10-28 Cerebrus Ltd Chemical compounds III
ATE310566T1 (de) * 1998-09-18 2005-12-15 Alcon Mfg Ltd 5ht2-agoniste zur behandlung des glaukoms

Also Published As

Publication number Publication date
CA2401959A1 (en) 2001-09-27
AU2001219180B2 (en) 2005-04-07
KR20030095183A (ko) 2003-12-18
ZA200206853B (en) 2004-11-02
CN1450995A (zh) 2003-10-22
EP1268439A1 (en) 2003-01-02
WO2001070701A1 (en) 2001-09-27
PL365422A1 (en) 2005-01-10
AR026708A1 (es) 2003-02-26
JP2003535821A (ja) 2003-12-02
MXPA02008825A (es) 2004-10-15
BR0017163A (pt) 2003-01-14

Similar Documents

Publication Publication Date Title
HUP0201111A3 (en) Shunt device for treating glaucoma
IL157875A0 (en) Pyrazole derivatives for treating hiv
AU1918001A (en) 5-hydroxy indazole derivatives for treating glaucoma
PL351611A1 (en) 4,5,6,7-tetrahydroindazole derivatives as antitumor agents
PL358481A1 (en) 6-hydroxy-indazole derivatives for treating glaucoma
GB2387821B (en) Working apparatus
HUP0105036A3 (en) Imidazo-quinolin derivatives for treating sexual disturbances
EP1414464A4 (en) METHOD OF TREATING GLAUCOMA
IL153325A0 (en) Colchinol derivatives as angiogenesis inhibitors
AU2403802A (en) Benzimidazole derivatives
GB0004063D0 (en) Adjusting apparatus
MY145215A (en) Vaginalli administered anti-dysrhythmic agents for treating uterine dysrhythmia
AU2001237939A1 (en) Methods for treating glaucoma
AU6387401A (en) Pyrrole derivatives for treating aids
EG24462A (en) Compounds for treating fundic disaccomodation
GB2358839B (en) Working apparatus
SI1322592T1 (en) Substituted 1-aminobutan-3-ol derivatives
AU1603401A (en) Pyranoindoles for treating glaucoma
HK1050195A (en) 5-hydroxy indazole derivatives for treating glaucoma
AU2001216035A1 (en) 5-hydroxy indole derivatives for treating glaucoma
AU2069602A (en) Process for preparing distamycin derivatives
GB0016447D0 (en) Process for preparing distamycin derivatives
HK1050196A (en) 6-hydroxy-indazole derivatives for treating glaucoma
HUP0004154A3 (en) Process for the preparation of 1,5-disubstituted-3-amino-1,2,4-triazole derivatives
HK1051979A (en) Methods for treating glaucoma